DE602004008912D1 - Retardiertes Freigabesystem mit kontrollierter Initialabgabe - Google Patents

Retardiertes Freigabesystem mit kontrollierter Initialabgabe

Info

Publication number
DE602004008912D1
DE602004008912D1 DE602004008912T DE602004008912T DE602004008912D1 DE 602004008912 D1 DE602004008912 D1 DE 602004008912D1 DE 602004008912 T DE602004008912 T DE 602004008912T DE 602004008912 T DE602004008912 T DE 602004008912T DE 602004008912 D1 DE602004008912 D1 DE 602004008912D1
Authority
DE
Germany
Prior art keywords
release system
core
initial delivery
retarded release
controlled initial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004008912T
Other languages
English (en)
Other versions
DE602004008912T3 (de
DE602004008912T2 (de
Inventor
Teppo Riihimaeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Schering Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34932022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004008912(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Oy filed Critical Schering Oy
Publication of DE602004008912D1 publication Critical patent/DE602004008912D1/de
Application granted granted Critical
Publication of DE602004008912T2 publication Critical patent/DE602004008912T2/de
Publication of DE602004008912T3 publication Critical patent/DE602004008912T3/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE602004008912T 2004-07-13 2004-07-13 Retardiertes Freigabesystem mit kontrollierter Initialabgabe Active DE602004008912T3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04396049A EP1629844B2 (de) 2004-07-13 2004-07-13 Retardiertes Freigabesystem mit kontrollierter Initialabgabe

Publications (3)

Publication Number Publication Date
DE602004008912D1 true DE602004008912D1 (de) 2007-10-25
DE602004008912T2 DE602004008912T2 (de) 2008-06-05
DE602004008912T3 DE602004008912T3 (de) 2012-09-13

Family

ID=34932022

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004008912T Active DE602004008912T3 (de) 2004-07-13 2004-07-13 Retardiertes Freigabesystem mit kontrollierter Initialabgabe

Country Status (24)

Country Link
US (1) US7850986B2 (de)
EP (1) EP1629844B2 (de)
JP (1) JP4881861B2 (de)
KR (1) KR20070035032A (de)
CN (1) CN1984639A (de)
AT (1) ATE372772T1 (de)
AU (1) AU2005261682B2 (de)
BR (1) BRPI0513295A (de)
CA (1) CA2569542C (de)
DE (1) DE602004008912T3 (de)
DK (1) DK1629844T4 (de)
ES (1) ES2293193T5 (de)
HK (1) HK1086751A1 (de)
IL (1) IL179846A (de)
MX (1) MX2007000433A (de)
NO (1) NO334931B1 (de)
NZ (1) NZ551823A (de)
PL (1) PL1629844T5 (de)
PT (1) PT1629844E (de)
RU (1) RU2412693C2 (de)
SI (1) SI1629844T1 (de)
UA (1) UA91337C2 (de)
WO (1) WO2006005794A1 (de)
ZA (1) ZA200610473B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1629844B2 (de) 2004-07-13 2012-04-18 Bayer Schering Pharma Oy Retardiertes Freigabesystem mit kontrollierter Initialabgabe
AU2005325213B2 (en) * 2004-08-04 2010-10-07 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
BR112014001450A2 (pt) * 2011-07-20 2017-07-18 F Kiser Patrick dispositivos intravaginais para distribuição de droga
MX351280B (es) 2012-01-18 2017-10-06 Worldwide Innovative Healthcare Inc Aposito cutaneo oclusivo modificable.
AR089765A1 (es) 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN105310974B (zh) * 2014-08-01 2019-08-23 山东绿叶制药有限公司 罗替戈汀及其衍生物或其药用盐的植入剂

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832252A (en) 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
RU2088166C1 (ru) 1993-08-10 1997-08-27 Педдер Валерий Викторович Способ контрацепции и устройство для его осуществления
BR9507313A (pt) 1994-04-08 1997-10-07 Atrix Lab Inc Composição liquida de liberação adequada para a formação de um implante de liberação controlada sistema polimérico curativo filmico microporoso biodegradável precursor de implante de liberação controlada para a implantação em um indivíduo polímero termoplástico solvente orgánico composicão de pré-polimero liquido componente de liberação controlada agente ativo uso da composição liquida de liberação e processos para forma um implante microporoso de liberação prolongada e para liberar um agente ativo em um individuo
US5492947A (en) * 1994-06-23 1996-02-20 Aspen Research Corporation Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
GB2290964A (en) 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
FI97947C (fi) 1994-09-27 1997-03-25 Leiras Oy Menetelmä lääkepreparaatin valmistamiseksi
GB9522403D0 (en) † 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
WO1999061062A1 (en) † 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes
AU6517900A (en) 1999-08-03 2001-02-19 Smith & Nephew, Inc. Controlled release implantable devices
DE10190041D2 (de) * 2000-01-11 2002-12-05 Roland Bodmeier Implantate, Partikel
US6299894B1 (en) * 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
CN1536986B (zh) 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的阴道内药物递送装置
CN1210079C (zh) 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
JP2005503389A (ja) * 2001-08-31 2005-02-03 シエーリング オサケユイチア 薬物送達システム
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
US20070043332A1 (en) † 2003-07-10 2007-02-22 Galen (Chemiclas) Liimited Intravaginal drug delivery devices
MXPA06010905A (es) * 2004-03-24 2007-03-08 Organon Nv Sistema para el suministro de farmacos basados en copolimeros de polietileno y acetato de vinilo.
EP1629844B2 (de) 2004-07-13 2012-04-18 Bayer Schering Pharma Oy Retardiertes Freigabesystem mit kontrollierter Initialabgabe

Also Published As

Publication number Publication date
ZA200610473B (en) 2008-06-25
AU2005261682A1 (en) 2006-01-19
CA2569542C (en) 2012-10-09
JP2008506672A (ja) 2008-03-06
NZ551823A (en) 2008-07-31
PT1629844E (pt) 2007-10-17
PL1629844T3 (pl) 2008-02-29
ATE372772T1 (de) 2007-09-15
HK1086751A1 (en) 2006-09-29
DK1629844T3 (da) 2007-10-15
MX2007000433A (es) 2007-03-07
DE602004008912T3 (de) 2012-09-13
EP1629844B2 (de) 2012-04-18
US20080031922A1 (en) 2008-02-07
WO2006005794A1 (en) 2006-01-19
NO20070805L (no) 2007-02-12
CA2569542A1 (en) 2006-01-19
AU2005261682B2 (en) 2010-02-11
RU2412693C2 (ru) 2011-02-27
PL1629844T5 (pl) 2012-10-31
NO334931B1 (no) 2014-07-14
CN1984639A (zh) 2007-06-20
DK1629844T4 (da) 2012-05-29
SI1629844T1 (sl) 2007-12-31
JP4881861B2 (ja) 2012-02-22
IL179846A (en) 2012-07-31
BRPI0513295A (pt) 2008-05-06
US7850986B2 (en) 2010-12-14
UA91337C2 (ru) 2010-07-26
ES2293193T3 (es) 2008-03-16
RU2006145900A (ru) 2008-06-27
ES2293193T5 (es) 2012-06-13
KR20070035032A (ko) 2007-03-29
EP1629844B1 (de) 2007-09-12
DE602004008912T2 (de) 2008-06-05
IL179846A0 (en) 2007-05-15
EP1629844A1 (de) 2006-03-01

Similar Documents

Publication Publication Date Title
NO20070805L (no) Medikamentavleveringssystem.
TW200631496A (en) One step fire ant control
WO2006102532A3 (en) Explicit overlay integration rules
DE60040173D1 (de) Präsenz- und sitzungsbehandlungsinformationen
GB2433765B (en) Control systems and methods for active controlled bottomhole pressure systems
BRPI0509695B8 (pt) Sulfoximinas n-substituídas, composição e método para controlar insetos
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
WO2007150018A3 (en) Steroid-containing sustained release intraocular implants and related methods
DE50200579D1 (de) Kraftstoffsystem, verfahren zum betreiben des kraftstoff-systems, computerprogramm sowie steuer- und/oder regelgerät zur steuerung des kraftstoffsystems
IL181243A0 (en) Method for controlling exposure system, exposure method and system using same, and method for manufacturing device
ATE495767T1 (de) Regelungsverfahren für die eluierung von therapeutischen wirkstoffen
DE502005004206D1 (de) Verwendung von 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylen-dihydrofuran-2-on zur bekämpfung von psylliden
TWI315412B (en) Optical level control device, method for controlling same, and laser application device
SE0203650D0 (sv) Pest controlling system
GB2414086B (en) Vibraion controller for active vibration insulators and method for controlling vibration for the same
GB2412549B (en) Call device, call control system, call management system, and call control method
MY122838A (en) Treating allergic and inflammatory conditions
MY152388A (en) Composition and method for controlling plant diseases
FI20041572A (fi) Kasvihuone, kasvihuoneen ilmastonsäätöjärjestelmä ja menetelmä kasvihuoneen ilmaston säätämiseksi
DK2004707T3 (da) Styret fordeling af aktive steder i Ziegler-Natta-katalysatorsystemer
WO2006015305A3 (en) Systems and methods for ion mobility control
ATE489805T1 (de) Audioverwaltung in einer dualprozessorumgebung
UA4196U (uk) Поліфіт-прополіс - біологічно активна домішка для профілактики та лікування інфекційних захворювань, туберкульозу, виразкової хвороби, підвищення імунітету
FI20041611A0 (fi) Menetelmä ja järjestelmä lähtevän puhelun ohjaamiseksi
IL160106A0 (en) Method and system for controlling the operation of insulin pumpsice and method for controlling insulin administration

Legal Events

Date Code Title Description
8363 Opposition against the patent